Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Cash & Current Investments: 2010-2018

Historic Cash & Current Investments for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to $38.8 million.

  • EyePoint Pharmaceuticals' Cash & Current Investments rose 165.38% to $43.4 million in Q1 2019 from the same period last year, while for Mar 2019 it was $183.2 million, marking a year-over-year increase of 216.08%. This contributed to the annual value of $38.8 million for FY2018, which is 129.47% up from last year.
  • EyePoint Pharmaceuticals' Cash & Current Investments amounted to $38.8 million in FY2018, which was up 129.47% from $16.9 million recorded in FY2017.
  • Over the past 5 years, EyePoint Pharmaceuticals' Cash & Current Investments peaked at $38.8 million during FY2018, and registered a low of $16.9 million during FY2017.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Cash & Current Investments value was $29.0 million (recorded in 2016), while the average stood at $28.2 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 41.71% in 2017, then skyrocketed by 129.47% in 2018.
  • EyePoint Pharmaceuticals' Cash & Current Investments (Yearly) stood at $18.3 million in 2014, then skyrocketed by 56.12% to $28.5 million in 2015, then grew by 1.60% to $29.0 million in 2016, then plummeted by 41.71% to $16.9 million in 2017, then surged by 129.47% to $38.8 million in 2018.